| Authors: |
Burger JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Barr PM; Department of Medicine, Hematology, and Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Robak T; Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Owen C; Division of Hematology and Hematological Malignancies, Tom Baker Cancer Centre, University of Calgary, Calgary, Canada., Tedeschi A; Department of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy., Sarma A; Department of Haematology, St. James's University Hospital, Leeds, United Kingdom., Patten PEM; Department of Haematology, Comprehensive Cancer Centre, King's College London, London, United Kingdom.; Department of Haematology, King's College Hospital, London, United Kingdom., Grosicki S; Department of Hematology and Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice, Poland., McCarthy H; Department of Haematological Medicine, Royal Bournemouth General Hospital, Bournemouth, United Kingdom., Offner F; Department of Haematology, Universitair Ziekenhuis Gent, Gent, Belgium., Szafer-Glusman E; Precision Medicine Oncology, AbbVie, North Chicago, IL., Zhou C; Translational Medicine, AbbVie, North Chicago, IL., Szoke A; Clinical Development Oncology, AbbVie, North Chicago, IL., Neumayr L; Clinical Development Oncology, AbbVie, North Chicago, IL., Dean JP; Clinical Development Oncology, AbbVie, North Chicago, IL., Ghia P; Department of Medical Oncology, Medical School, Università Vita-Salute San Raffaele, Milan, Italy.; Division of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy., Kipps TJ; Division of Hematology-Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA. |
